Product Information
BUDESONIDE EC 3 MG CAPSULE is a generic product labeled by Mayne Pharma, priced at $0.5154 per EA under NDC 51862058001. Its NADAC has been published 321 times since Feb 12, 2020.
FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Mayne PharmaNDC
51862058001
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206623FDA Approved
4/8/2016
TE Code
AB
On Market Since
10/31/2019
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE EC 3 MG CAPSULE has been published 321 times since Feb 12, 2020, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5154 per EA |
|---|---|
| All-time high | $1.8078 (Apr 15, 2020) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5221 |
| 52-week low | $0.5024 |
| Median price | $0.6829 |
| Average price | $0.7841 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 321 |
| Tracking since | Feb 12, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.1%
3Y
-16.5%
5Y
-42.7%
All
-70.8%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE EC 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE EC 3 MG CAPSULE, manufactured by Mayne Pharma, is $0.5154 per EA (NDC 51862058001), effective Apr 1, 2026.
How has the price of BUDESONIDE EC 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE EC 3 MG CAPSULE has declined 70.8%. It has been tracked across 321 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for BUDESONIDE EC 3 MG CAPSULE?
Since Feb 12, 2020, the NADAC for BUDESONIDE EC 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $1.8078 (Apr 15, 2020), with a median of $0.6829 per EA.
Are there cheaper alternatives to BUDESONIDE EC 3 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE DR 3 MG CAPSULE, is $0.4975 per EA — about 3% below BUDESONIDE EC 3 MG CAPSULE.
Who manufactures BUDESONIDE EC 3 MG CAPSULE?
BUDESONIDE EC 3 MG CAPSULE (NDC 51862058001) is labeled by Mayne Pharma, and CMS classifies it as a generic product.